Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
about
Theranostic impact of NG2/CSPG4 proteoglycan in cancerLack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).Immunophenotyping of acute leukemias and myelodysplastic syndromes.Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesInsights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.MLL-ENL cooperates with SCF to transform primary avian multipotent cells.A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia.
P2860
Q28085331-67444AD6-C0A2-4837-8FD5-F7031EAF9A30Q34518408-89B96C71-F647-43B2-B5AF-03E464AA948FQ35679885-168F2B27-115E-45F4-B523-E1931BE9A1FFQ37340948-3CC8A621-75C7-46E9-AB53-F05365E0CF28Q37816933-25C7D5C9-F1A1-4BC1-9409-DFE572FF59EBQ37831107-3205F554-B610-4CDF-AEF0-2ECC5F02D8CCQ39631034-83A63CDB-517B-4DCA-A587-F249C076A470Q39645001-F0FD280B-5FCB-414C-861A-5CA8AEBAAF0AQ40002915-BE86901A-D605-47E2-83BC-0438EA116EBAQ40571894-2C083436-E535-42D5-B9D0-60CAFBB97CB8Q42832529-E2667551-6478-45B1-B0DF-A3BC5302E089Q47555734-A3C5C1AE-958C-4E07-A976-D2B0D4060160Q47729253-B25F2EBB-E9D1-4B60-B940-BD7DA96842C4Q47930875-6B328F06-6A72-42E8-AB77-9CFB847098C2Q51021578-69908B52-6DFE-4AA2-84A8-A28EBBCA5459
P2860
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@ast
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@en
Detection of acute leukemia cells with mixed lineage leukemia
@nl
type
label
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@ast
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@en
Detection of acute leukemia cells with mixed lineage leukemia
@nl
prefLabel
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@ast
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@en
Detection of acute leukemia cells with mixed lineage leukemia
@nl
P2093
P356
P1433
P1476
Detection of acute leukemia ce ...... using monoclonal antibody 7.1.
@en
P2093
Borkhardt A
Creutzig U
Haferlach T
Karawajew L
Schnittger S
P2888
P304
P356
10.1038/SJ.LEU.2401840
P577
2000-07-01T00:00:00Z
P5875
P6179
1004100045